Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00853528 · ClinicalTrials.gov registry record · Phase 1
Stereotactic Radiosurgery in Treating Patients With Spinal Metastases
A Phase 1 study, sponsored by Boston Medical Center.
- Completed
- Registry status
- Phase 1
- Development phase
- 18
- Enrollment target
NCT00853528 is a Phase 1 study that has completed, run by Boston Medical Center. The registered enrollment target is 18 participants.
The verdict
NCT00853528, a Phase 1 study, has completed, sponsored by Boston Medical Center.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 18 participants
- Enrollment target
Study Summary
RATIONALE: Stereotactic radiosurgery can send x-rays directly to the tumor and cause less damage to normal tissue. It may also help patients with spinal metastases live more comfortably. PURPOSE: This phase I trial is studying the side effects and best dose of stereotactic radiosurgery in treating patients with spinal metastases.
Interventions
- OTHER questionnaire administration
- PROCEDURE diffusion tensor imaging
- PROCEDURE functional magnetic resonance imaging
- RADIATION single-fraction SRS
- RADIATION hypo-fractionated SRS
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 18 participants |
| Start Date | 2009-01 |
| Est. Completion | 2017-06 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00853528
The ClinicalTrials.gov registry entry for NCT00853528 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 18 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Boston Medical Center, which has 253 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 5 interventions - of which questionnaire administration is the first listed.
NCT00853528 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00853528 about?
NCT00853528 is a clinical study titled "Stereotactic Radiosurgery in Treating Patients With Spinal Metastases". RATIONALE: Stereotactic radiosurgery can send x-rays directly to the tumor and cause less damage to normal tissue. It may also help patients with spinal metastases live more comfortably. PURPOSE: This phase I trial is studying the side effects and best dose of stereotactic radiosurgery in treating ...
What is the current status of trial NCT00853528?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 18 participants. The study started on 2009-01. Estimated completion is 2017-06.
What interventions are being tested in trial NCT00853528?
The interventions under investigation include: questionnaire administration (OTHER), diffusion tensor imaging (PROCEDURE), functional magnetic resonance imaging (PROCEDURE), single-fraction SRS (RADIATION), hypo-fractionated SRS (RADIATION).
Who is sponsoring clinical trial NCT00853528?
This trial is sponsored by Boston Medical Center, which has 253 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.